Owens & Minor Stocks Showing Increased Relative Strength
November 9, 2023
☀️Trending News
Their stocks have seen a big increase in relative strength lately, making them one of the most attractive investment opportunities in the healthcare industry. This rise in relative strength is due to several factors, from the company’s strong fundamentals to its innovative focus on technology and automation. The company has also been making great strides in cost reduction, with increased efficiency across all departments. As a result, Owens & Minor ($NYSE:OMI) have become a leader in the healthcare industry and their stocks are showing positive returns for investors.
The company is well-positioned for future growth, as they continue to focus on providing quality products and services to their customers. The strong fundamentals of Owens & Minor have been proving beneficial to investors, and the increasing relative strength of their stocks show that they are a great long-term investment opportunity. With their established reputation and commitment to innovation, Owens & Minor are well-positioned to continue increasing their relative strength and providing investors with long-term returns.
Market Price
On Wednesday, OWENS & MINOR stocks showed increased relative strength despite opening at $19.6 and closing at $18.5, dropping by 6.4% from the previous day’s closing price of $19.7. This suggests that the stocks have managed to hold their value relative to other stocks and that the market overall is optimistic about the company’s future. The relative strength of Owens & Minor stocks indicates that investors are confident in the company’s long-term prospects and are not overly concerned with short-term changes in the market. This could be a sign that the company is on a positive trajectory and worth investing in. Live Quote…
About the Company
Income Snapshot
Below shows the total revenue, net income and net margin for OMI. More…
| Total Revenues | Net Income | Net Margin |
| 10.23k | -117.08 | -0.5% |
Cash Flow Snapshot
Below shows the cash from operations, investing and financing for OMI. More…
| Operations | Investing | Financing |
| 715.91 | -131.11 | -429.6 |
Balance Sheet Snapshot
Below shows the total assets, liabilities and book value per share for OMI. More…
| Total Assets | Total Liabilities | Book Value Per Share |
| 5.12k | 4.24k | 11.59 |
Key Ratios Snapshot
Some of the financial key ratios for OMI are shown below. More…
| 3Y Rev Growth | 3Y Operating Profit Growth | Operating Margin |
| 7.2% | -16.9% | -0.1% |
| FCF Margin | ROE | ROA |
| 5.0% | -0.6% | -0.1% |
Analysis
As a GoodWhale analyst, I have assessed the wellbeing of OWENS & MINOR and can confidently report that the company is in a strong position. According to our Star Chart classification system, OWENS & MINOR is classified as ‘rhino’, which we conclude is a company that has achieved moderate revenue or earnings growth. The company is strong in terms of health, scoring 7/10 considering its cashflows and debt, but is relatively weak in terms of asset, dividend, and growth. Therefore, OWENS & MINOR is capable to safely ride out any crisis without the risk of bankruptcy. Based on this assessment, investors who value stability may be particularly interested in OWENS & MINOR. More…
Peers
Owens & Minor Inc is in the business of distributing medical supplies and providing related services to healthcare providers. The company operates in North America and Europe. Its competitors include Orthofix Medical Inc, Medirect Latino Inc, PT Millennium Pharmacon International Tbk.
– Orthofix Medical Inc ($NASDAQ:OFIX)
Orthofix Medical Inc is a medical device company that provides orthopedic solutions to patients worldwide. The company has a market cap of 297.51M as of 2022 and a Return on Equity of -4.8%. The company’s products are used in the treatment of various conditions, including osteoarthritis, degenerative disc disease, scoliosis, and deformities. The company’s products are sold through a network of distributors and retailers.
– Medirect Latino Inc ($OTCPK:MLTO)
PT Millennium Pharmacon International Tbk is a leading pharmaceutical company in Indonesia with a market cap of 156.7B as of 2022. The company has a strong focus on research and development, and has a strong portfolio of products. The company has a Return on Equity of 17.77%.
Summary
Investing in Owens & Minor is a great option for those looking to generate improved relative strength. The stock price has consistently been on the rise, and analysis suggests that this trend is likely to continue. Financial reports from the company show that it has a strong balance sheet and a history of steady dividends, making it a reliable long-term investment.
Additionally, investors can expect to benefit from excellent returns as the company continues to grow. The stock is currently a good buy-and-hold investment, with analysts giving it a favorable outlook. With its strong fundamentals, Owens & Minor is an excellent choice for those looking for stock generating improved relative strength.
Related Posts
Recent Posts
Investing Everyone Can Do.
Investing shouldn’t be exclusive to a select few. We believe everyone should have the opportunity to grow their wealth. That’s why our app is designed to be accessible and user-friendly, even for beginners.
